Top Questions About Non-Small Cell Lung Cancer - HealthCentral.com

If your tumor has a "driver mutation" (cells that have a genetic mutation that is driving them to divide and spread), the first-line treatment is a drug in a category called targeted therapy, says Afshin Dowlati, M.D., a professor of medicine and oncology at Case Western Reserve University in Cleveland, OH. These drugs target that mutation and aim to halt cancer-cell growth. For example, osimertinib is the standard of care targeting an EGFR mutation, adds Dr. Dowlati.

Adblock test (Why?)

Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Respirology | APSR Respiratory Medicine Journal

Free biotech stocks directory, pharma stocks, telemedicine stocks ...